On 21 September 2023:
On 31 January 2024:
So it sounds like they covered the potency assay requirement for GVHD001.
But why didn't they include any paragraph about the current inventory being "similar" or "standardised" in the 4C announcement other than the comment that it is "greater". Is it because it's not? Or do they just need to improve their communication skills?
They need to scratch where investors are feeling the most itchy.
Ryoncil - potency assay data
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.09 | $1.05 | $1.337M | 1.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 69821 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 34013 | 16 |
View Market Depth
| Last trade - 12.25pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.06 |
Change
-0.005 ( 2.14 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.09 | $1.06 | 349666 | ||
| Last updated 12.45pm 12/06/2024 ? | |||||
| MSB (ASX) Chart |